Abstract
In idiopathic thrombocytopenic purpura (ITP), platelets are destroyed in the spleen, liver and bone marrow (BM) by autoantibodies and cytotoxic T-cells. In a DNA microarray screen of peripheral blood T-cells, we found that VLA-4, CX3CR1 and CXCR4, involved in T-cell homing, had increased expression in ITP patients compared with controls. However, we only found increased protein expression of VLA-4 on T- 
Introduction
Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disease where platelets are destroyed prematurely, mainly in the spleen, liver and bone marrow. Besides the wellknown autoantibody-mediated destruction of platelets in the reticuloendothelial systems, [1] [2] [3] [4] several T-cell abnormalities have been identified in ITP. CD4 + T-helper cells from ITP patients have been shown to secrete interleukin 2 (IL-2) upon stimulation with autologous platelets. 5, 6 Clonal expansion of CD4 + T-helper cells has also been reported 7 and it has been shown that T-cells from ITP patients can proliferate in vitro by GPIIb/IIIa stimulation. 8, 9 We have previously demonstrated that platelets in ITP can be directly destroyed by CD8 + T-cell mediated cytotoxicity, 10 and that activation-induced cell death (AICD) of T-cells is impaired. 11 A CD8+ T-cell mediated platelet lysis in ITP has also been reported by Zhang and co-workers. 12 We and others have shown that ITP during active phase is associated with a Th1 cytokine profile, 13, 14 i.e. secretion of interferon gamma (IFN-γ) and tumor necrosis factor alpha (TNF-α), whereas remission is associated with an elevated level of transforming growth factor beta 1 (TGF-β1), 14, 15 i.e. a Th3
profile.
Recent studies of immune responses have revealed that cells respond to an activation signal with waves of co-ordinated gene expression that can be monitored by global expression profiling using DNA microarray technology. 16 The components of these responses are probably the key to understanding the specific mechanisms that lead to phenotypic differentiation. In the present study we analyzed genes and proteins involved 
Materials and methods

Subjects
In this study a total of 26 chronic ITP patients were identified from our roster of ITP patients. All patients were treated at the Hematology Section at Sahlgrenska University Hospital in Gothenburg. Besides from a thorough history and physical examination, a bone marrow examination on biopsy and/or aspiration material, were performed in all patients at presentation together with sonography or scintigraphy of the spleen, and full blood counts. Antibody screen for a rheumatic condition and tests for hepatitis C and HIV were also undertaken in most cases. To be included in the present studies the patients had to have an unequivocal diagnosis of chronic ITP and had to consent to the proposed studies. The criteria for chronic ITP were: (i) isolated thrombocytopenia lasting for more than six months and a platelet count <100 x 10 9 /L, (ii) normal bone marrow examination, (iii) normal sized spleen, and (iv) no other cause for their thrombocytopenia. Fresh blood was collected from 10 patients and fresh bone marrow, for flow cytometry, from 6 patients. In 17 patients bone marrow biopsies, obtained at diagnosis and prior to treatment, were identified retrospectively, and analyzed by immunohistochemistry. The patients' characteristics are given in Table 1 . Twenty healthy individuals, 14 females and 6 males (aged 36±6.4 (SD) years) were used as controls. All studies were approved by the local ethics committee at University of Gothenburg and all participants gave informed consent according to the declaration of Helsinki. Preparation of RNA and hybridization to DNA microarrays RNA was isolated from the CD3 + T-cell preparations using the Chomczynski method, 18 followed by RNeasy clean up (Qiagen, Hilden, Germany). The RNA concentration was measured spectrophotometrically with an A260/A280 ratio of 1.8-2.0, and the quality was verified by agarose gel electrophoresis. The RNA from the 5 individuals in each group, i.e. ITP patients and controls, was pooled in equal amounts. Each pool was analyzed in duplicates as described. 10 Briefly, RNA was transcribed into cDNA (Life Technologies, Rockville, MD) and biotin-labeled cRNA (Enzo, Farmingdale, NY) was resynthesized.
Hybridization to DNA microarrays (Human Genome U95A array version 2; Affymetrix, only.
For personal use at PENN STATE UNIVERSITY on February 20, 2013. bloodjournal.hematologylibrary.org From Santa Clara, CA) and detection of hybridized target cRNA was performed according to the Affymetrix Gene Chip Expression Analysis manual. Quality of the cDNA-synthesis and in vitro transcription was assessed by hybridization to Test2-arrays (Affymetrix).
Data analysis
Scanned output files were visually inspected for hybridization artifacts and then analyzed with MicroarraySuite 5.0 software (Affymetrix). To identify regulated genes the duplicate arrays were scaled to an average intensity of 500 and compared in a crosswise fashion 19 using a change call parameter in the MicroarraySuite 5.0 software. These experiments comply with Minimum Information About a Microarray Experiment (MIAME) 20 and all files have been deposited in the gene expression omnibus database (GSE574).
Flow cytometry
A routine protocol for preparation of PBMC, from EDTA anticoagulated blood and bone marrow specimens, by Ficoll-separation was used. T-cell expression of CX3CR1, VLA-4, CXCR4, Fas and CD25 was analyzed in a 5 color combination using anti-CD3- 
Analysis of fractalkine (CX3CL1) levels in blood and bone marrow plasma
The levels of fractalkine were analyzed in EDTA-anticoagulated blood and bone marrow plasma obtained from 6 ITP patients and 7 healthy individuals using a commercial available assay for human fractalkine (R&D systems Europe Ltd., Abingdon, UK).
Immunohistochemistry of bone marrow biopsies
In 17 ITP patients a high quality bone marrow biopsy was available from the diagnostic work-up at presentation and before start of treatment. All these patients have been
prospectively followed for at least six month and fulfilled the criteria of chronic ITP.
Biopsies obtained from 7 healthy subjects served as controls. Five micron thick sections from the paraffin embedded biopsies were stained with haematoxylin-eosin and immunostained with antibodies against CD3, CD4, CD8 and CD20 using the Dako Envision System in a Techmate Horizon Autostainer (Glostrup, Denmark). The number 
Results
DNA microarray analysis
We investigated the expression of molecules involved in T-cell homing in ITP patients and controls by DNA microarray analysis of RNA from peripheral blood T-cells. We found that the mRNA expression of the integrin VLA-4, and the chemokine receptors CX3CR1 and CXCR4 was increased in ITP patients compared with controls (Fig 2) .
Flow cytometric analysis of homing receptors, activation markers and regulatory Tcells in blood and bone marrow of ITP patients and controls
In peripheral blood, there was no statistically significant difference in the percentage of P=0.004) from ITP patients compared with controls (Fig 3) . The surface expression of CXCR4 on T-cells was not statistically significant between ITP patients and controls (687±170 vs 880±371, controls and ITP, respectively; P=0.65).
only.
For (Fig 4; 9.5±1.2% vs. 6.5±1.1%, controls and ITP, respectively; P=0.10).
Analysis of fractalkine levels in ITP patients and controls
We analyzed blood and bone marrow plasma levels of fractalkine in ITP patients and controls. There was no statistically significant difference in blood or bone marrow plasma levels of fractalkine between ITP patients and controls (blood plasma, 10.4±3.6 vs. respectively). However, in both groups the levels of fractalkine were higher in bone marrow plasma compared with blood plasma (P=0.037).
5.2±1.4 ng
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Analysis of T-cells, B-cells and monocytes/macrophages in blood and bone marrow of ITP patients and controls
We analyzed the number of T-cells, B-cells and monocytes/macrophages in bone marrow by flow cytometry in 6 ITP patients and 6 controls. We found an increased number of Tcells (Fig 5; ITP 80 only.
For personal use at PENN STATE UNIVERSITY on February 20, 2013. bloodjournal.hematologylibrary.org From and CD45Ra in ITP patients and controls as previously described. 21 However, we found no statistically significant difference between ITP patients and controls (data not shown).
Discussion
In chronic ITP platelets are prematurely destoyed in the spleen, liver and bone marrow. In the present study we found an increased number of T-cells in bone marrow of ITP patients compared with controls, a finding that emphasizes the importance of T-cells in the pathogenesis of the disease. Furthermore, our data also suggest that VLA-4 and CX3CR1 may be of importance in recruiting T-cells into the organs where the platelet destruction takes place.
Both the mRNA and protein expression of VLA-4 was increased in peripheral blood Tcells from ITP patients compared with controls. Furthermore, protein expression of VLA-4 was also increased in bone marrow T-cells in ITP. VLA-4 is known to be expressed on activated T-cells 22 and promotes trafficking of CD8 + T-cells to the bone marrow. 23, 24 Indeed, in this study we found an increased mean fluorescence intensity of VLA-4 on CD8 + T-cells in the bone marrow suggesting that VLA-4 expressing CD8 + T-cells may be recruited into the bone marrow which is known to participate in platelet destruction.
VLA-4 has also been implicated in several diseases like multiple sclerosis, Crohn's disease and atherosclerosis. In these conditions, VLA-4 is vital for T-cell recruitment into target tissues. The importance of this reaction is further illustrated by the favorable effect of natalizumab, a monoclonal anti-VLA-4 IgG4 antibody, in multiple sclerosis and
Crohn's disease. 25, 26 In addition to the up-regulation of VLA-4, we also found increased expression of CX3CR1 in peripheral T-cells from ITP patients by DNA microarray analysis. The only.
For personal use at PENN STATE UNIVERSITY on February 20, 2013. bloodjournal.hematologylibrary.org From increased T-cell expression of CX3CR1 in ITP was confirmed in bone marrow but not in blood by flow cytometry. CX3CR1 is the specific receptor for the chemokine fractalkine (CX3CL1). Fractalkine exist in two forms, a membrane bound form and a soluble form released by proteolytic cleavage. 27 We did not find any significant difference in blood or bone marrow plasma levels of fractalkine between ITP patients and control. However, fractalkine levels were elevated in bone marrow plasma, compared with blood, in both groups. Thus, this suggests that, in ITP, the increased expression of CX3CR1 alone is a sufficient chemokine signal for trafficing of T-cells from peripheral blood into the bone marrow. CX3CR1 is expressed on NK-cells and CD8+ T-cells, and most of them are positive for granzyme B. 28 CD8 + T-cells in bone marrow are known to mainly be central memory cells (T CM ) giving lifelong specificity for antigens. 29 Interestingly, CX3CR1 appears to be the main receptor for homing of CD8 + cells in AIDS. 30 The interaction between fractalkine and CX3CR1 on effector lymphocytes in endothelium is enough for adhesion and tissue recruitment. Several studies have demonstrated low levels of regulatory T-cells (T-regs) in blood of ITP patients. 34, 35 However, no studies have been performed on bone marrow specimens only.
For personal use at PENN STATE UNIVERSITY on February 20, 2013. bloodjournal.hematologylibrary.org From from ITP patients. We found a trend towards lower levels in blood and significantly lower levels of T-regs in bone marrow from ITP patients compared with controls. T-regs produce transforming growth factor beta 1 (TGFβ1) that suppresses Th1 response, proliferation, activation and differentiation of T cells. 36 The importance of T-reg derived TGFβ1 in autoimmunity is illustrated by the findings that both complete TGFβ1 deletion 37 and T-cell specific deletion of TGFβ1 in mice results in multifocal inflammatory disease. 36 Our data support the prevailing theory of ITP as a Th1 disease; a low level of TGFβ1 in ITP up-regulates the Th1 response and promotes the destruction of platelets both by autoantibodies and T-cell mediated cytotoxicity. It can also be hypothesized that this mechanism might contribute to the suppressed megakaryocyte production seen in ITP. 38 Fas is a marker of T-cell activation 39 and we have previously shown that Fas mRNA is increased in peripheral blood T-cells from ITP patients. 10 In this study, we could show 
